Reverse shoulder arthroplasty in patients aged 65 years or younger: a systematic review of the literature.

Reverse shoulder arthroplasty complications functional outcomes revision arthroplasty systematic review young population

Journal

JSES open access
ISSN: 2468-6026
Titre abrégé: JSES Open Access
Pays: Netherlands
ID NLM: 101738952

Informations de publication

Date de publication:
Oct 2019
Historique:
entrez: 12 11 2019
pubmed: 12 11 2019
medline: 12 11 2019
Statut: epublish

Résumé

Reverse shoulder arthroplasty (RSA) is offered to young patients with a failed previous arthroplasty or a cuff-deficient shoulder, but the overall results are still uncertain. We conducted a systematic review of the literature to report the midterm outcomes and complications of RSA in patients younger than 65 years. A search of the MEDLINE and Cochrane electronic databases identified clinical studies reporting the results, at a minimum 2-year follow-up, of patients younger than 65 years treated with an RSA. The methodologic quality was assessed with the Methodological Index for Non-Randomized Studies score by 2 independent reviewers. Complications, reoperations, range of motion, functional scores, and radiologic outcomes were analyzed. Eight articles were included, with a total of 417 patients. The mean age at surgery was 56 years (range, 21-65 years). RSA was used as a primary arthroplasty in 79% of cases and revision of a failed arthroplasty in 21%. In primary cases, the indications were cuff tear arthropathy and/or massive irreparable cuff tear in 72% of cases. The overall complication rate was 17% (range, 7%-38%), with the most common complications being instability (5%) and infection (4%). The reintervention rate was 10% at 4 years, with implant revision in 7% of cases. The mean weighted American Shoulder and Elbow Surgeons score, active forward elevation, and external rotation were 64 points, 121°, and 29°, respectively. RSA provides reliable clinical improvements in patients younger than 65 years with a cuff-deficient shoulder or failed arthroplasty. The complication and revision rates are comparable to those in older patients.

Sections du résumé

BACKGROUND BACKGROUND
Reverse shoulder arthroplasty (RSA) is offered to young patients with a failed previous arthroplasty or a cuff-deficient shoulder, but the overall results are still uncertain. We conducted a systematic review of the literature to report the midterm outcomes and complications of RSA in patients younger than 65 years.
METHODS METHODS
A search of the MEDLINE and Cochrane electronic databases identified clinical studies reporting the results, at a minimum 2-year follow-up, of patients younger than 65 years treated with an RSA. The methodologic quality was assessed with the Methodological Index for Non-Randomized Studies score by 2 independent reviewers. Complications, reoperations, range of motion, functional scores, and radiologic outcomes were analyzed.
RESULTS RESULTS
Eight articles were included, with a total of 417 patients. The mean age at surgery was 56 years (range, 21-65 years). RSA was used as a primary arthroplasty in 79% of cases and revision of a failed arthroplasty in 21%. In primary cases, the indications were cuff tear arthropathy and/or massive irreparable cuff tear in 72% of cases. The overall complication rate was 17% (range, 7%-38%), with the most common complications being instability (5%) and infection (4%). The reintervention rate was 10% at 4 years, with implant revision in 7% of cases. The mean weighted American Shoulder and Elbow Surgeons score, active forward elevation, and external rotation were 64 points, 121°, and 29°, respectively.
CONCLUSIONS CONCLUSIONS
RSA provides reliable clinical improvements in patients younger than 65 years with a cuff-deficient shoulder or failed arthroplasty. The complication and revision rates are comparable to those in older patients.

Identifiants

pubmed: 31709356
doi: 10.1016/j.jses.2019.06.003
pii: S2468-6026(19)30021-X
pmc: PMC6835024
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

162-167

Informations de copyright

© 2019 The Authors.

Références

J Bone Joint Surg Am. 2007 Jul;89(7):1476-85
pubmed: 17606786
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
J Bone Joint Surg Am. 2013 Oct 16;95(20):1877-83
pubmed: 24132362
J Shoulder Elbow Surg. 2018 Jun;27(6S):S24-S28
pubmed: 29307669
Syst Rev. 2012 Feb 09;1:2
pubmed: 22587842
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
J Shoulder Elbow Surg. 2019 Apr;28(4):774-781
pubmed: 30674426
J Bone Joint Surg Am. 2016 Jun 1;98(11):893-9
pubmed: 27252433
Clin Orthop Relat Res. 2018 Jun;476(6):1264-1273
pubmed: 29601384
J Shoulder Elbow Surg. 2012 Nov;21(11):1526-33
pubmed: 22445158
J Arthroplasty. 1988;3(1):39-46
pubmed: 3361319
Clin Orthop Relat Res. 2006 Jan;442:121-30
pubmed: 16394750
J Shoulder Elbow Surg. 2017 Jan;26(1):e13-e17
pubmed: 27522342
Orthop Rev (Pavia). 2017 Feb 24;9(1):6977
pubmed: 28286622
J Orthop Trauma. 2016 Feb;30(2):e41-7
pubmed: 26270461
J Shoulder Elbow Surg. 2017 May;26(5):792-797
pubmed: 28034540
J Bone Joint Surg Am. 2014 Dec 17;96(24):2070-6
pubmed: 25520341
J Shoulder Elbow Surg. 2005 Jan-Feb;14(1 Suppl S):147S-161S
pubmed: 15726075
J Shoulder Elbow Surg. 2017 Jul;26(7):1298-1306
pubmed: 28209327
Clin Orthop Relat Res. 1987 Jan;(214):160-4
pubmed: 3791738
J Bone Joint Surg Am. 2013 Jul 17;95(14):1297-304
pubmed: 23864178
J Bone Joint Surg Am. 2000 Apr;82(4):505-15
pubmed: 10761941
J Shoulder Elbow Surg. 2014 Jul;23(7):1036-42
pubmed: 24929746
J Shoulder Elbow Surg. 2014 Mar;23(3):395-400
pubmed: 24129052
Orthopade. 2017 Dec;46(12):1063-1072
pubmed: 29058027
J Hand Surg Am. 2019 Feb;44(2):104-111
pubmed: 30712650
Acta Orthop. 2019 Apr;90(2):119-122
pubmed: 30669910
J Shoulder Elbow Surg. 1994 Nov;3(6):347-52
pubmed: 22958838
J Shoulder Elbow Surg. 2013 Sep;22(9):1199-208
pubmed: 23385083
J Shoulder Elbow Surg. 2014 Mar;23(3):388-94
pubmed: 24021159
J Shoulder Elbow Surg. 2011 Jan;20(1):146-57
pubmed: 21134666
J Shoulder Elbow Surg. 2014 Nov;23(11):1647-54
pubmed: 24986694

Auteurs

Mikaël Chelli (M)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Lucas Lo Cunsolo (L)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Marc-Olivier Gauci (MO)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Jean-François Gonzalez (JF)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Peter Domos (P)

Royal Free London NHS Foundation Trust, London, UK.

Nicolas Bronsard (N)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Pascal Boileau (P)

Institut Universitaire Locomoteur et du Sport, University Hospital of Nice, Nice, France.

Classifications MeSH